BioNexus Gene Lab (BGLC) Beginning Cash Balance (2019 - 2020)
BioNexus Gene Lab recorded quarterly Beginning Cash Balance of $859076.0 in Q1 2020, down 31.83% quarter-over-quarter from $1.3 million in Q1 2019, and down 31.83% year-over-year from $1.3 million in Q2 2019.
BioNexus Gene Lab's Beginning Cash Balance history runs 2 years deep, the most recent figure standing at $859076.0 for Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 859,076.00 |
| Mar 31, 2020 | 859,076.00 |
| Mar 31, 2019 | 1.26 Mn |
| Mar 31, 2019 | 1.26 Mn |